AnHeart Therapeutics
0 followers
AnHeart Therapeutics (“AnHeart”) is a clinical-stage global biopharmaceutical company developing a broad pipeline of novel precision oncology therapeutics with high unmet medical needs. Its lead asset, taletrectinib, is a potential best-in-class next-generation ROS1 inhibitor currently in Phase 2 tr... Read more
Industries
Headquarters
Employees
Links
Org chart
Junyuan Jerry Wang
CEO & Co-Founder
Junyuan Jerry Wang
Collapse
Bing Yan
Co-Founder & Chief Medical Officer
Shuanglian Lian Li
SVP & Chief Medical Officer, US
Qinying Zhao
SVP & Head of Global Clinical Pharmacology
Hua Zheng
SVP & Head of Global Regulatory Affairs
Chen Lu
Associate Counsel/senior Legal Manager
Dawn Spooner
Senior Director of Regulatory Affairs
Eric Kong
CMC Director
Huan Huang
Senior director, pharmacovigilance
Xin (Shaun) Yang
Senior DM Manager
